
Flemming Ornskov
CEO of Shire plc
Education
- MD - University of Copenhagen
- MBA - INSEAD
- Master of Public Health - Harvard University
Overview
Flemming Ornskov is a Danish businessman. He has been the chief executive officer (CEO) of Galderma since October 2019.
He was previously the CEO of Shire plc, a FTSE 100 specialty biopharmaceutical company as of 30 April 2013, succeeding Angus Russel. He previously worked for Bayer, Bausch & Lomb and Novartis.
He is also the chairman of Waters Corporation.
Ørnskov received his MD from the University of Copenhagen, followed by an MBA from INSEAD, and a Master of Public Health (MPH) from Harvard University.
Early Life
Flemming Ornskov born 1957/58
Career
- Shire plc - CEO
Recognition
Top 100 Best-Performing CEOs in the World, 2015 - Harvard Business Review
Top 25 Most Influential People in Biopharma Today, 2013 - Fierce Biotech